These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 18628721)
21. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3. Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193 [TBL] [Abstract][Full Text] [Related]
22. Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture. Shields CL; Say EAT; Hasanreisoglu M; Saktanasate J; Lawson BM; Landy JE; Badami AU; Sivalingam MD; Hauschild AJ; House RJ; Daitch ZE; Mashayekhi A; Shields JA; Ganguly A Ophthalmology; 2017 Oct; 124(10):1523-1531. PubMed ID: 28495150 [TBL] [Abstract][Full Text] [Related]
23. Regression of uveal melanoma after ru-106 brachytherapy and thermotherapy based on metabolic activity measured by positron emission tomography/computed tomography. Lee CS; Lee SC; Lee K; Kwon HJ; Yi JH; Cho A Retina; 2014 Jan; 34(1):182-7. PubMed ID: 23719400 [TBL] [Abstract][Full Text] [Related]
24. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Maat W; Jordanova ES; van Zelderen-Bhola SL; Barthen ER; Wessels HW; Schalij-Delfos NE; Jager MJ Arch Pathol Lab Med; 2007 Jan; 131(1):91-6. PubMed ID: 17227129 [TBL] [Abstract][Full Text] [Related]
25. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Lake SL; Coupland SE; Taktak AF; Damato BE Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121 [TBL] [Abstract][Full Text] [Related]
26. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534 [TBL] [Abstract][Full Text] [Related]
27. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study. Kaliki S; Shields CL; Rojanaporn D; Badal J; Devisetty L; Emrich J; Komarnicky L; Shields JA Ophthalmology; 2013 May; 120(5):1004-11. PubMed ID: 23347983 [TBL] [Abstract][Full Text] [Related]
28. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. Shields CL; Ganguly A; Bianciotto CG; Turaka K; Tavallali A; Shields JA Ophthalmology; 2011 Feb; 118(2):396-401. PubMed ID: 20869116 [TBL] [Abstract][Full Text] [Related]
29. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674 [TBL] [Abstract][Full Text] [Related]
30. In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up. Midena E; Bonaldi L; Parrozzani R; Radin PP; Boccassini B; Vujosevic S Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):609-14. PubMed ID: 17934749 [TBL] [Abstract][Full Text] [Related]
31. Early macular morphological changes following plaque radiotherapy for uveal melanoma. Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; Shields JA Retina; 2008 Feb; 28(2):263-73. PubMed ID: 18301032 [TBL] [Abstract][Full Text] [Related]
32. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects. Baggetto LG; Gambrelle J; Dayan G; Labialle S; Barakat S; Michaud M; Grange JD; Gayet L Cancer Treat Rev; 2005 Aug; 31(5):361-79. PubMed ID: 15994016 [TBL] [Abstract][Full Text] [Related]
33. [Brachytherapy in choroidal melanoma]. Starzycka M; Słomska J; Romanowska B Klin Oczna; 1999; 101(1):19-22. PubMed ID: 10401209 [TBL] [Abstract][Full Text] [Related]
34. Pigmented episcleral deposits after brachytherapy of uveal melanoma. Toivonen P; Kivelä T Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837 [TBL] [Abstract][Full Text] [Related]
36. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574 [TBL] [Abstract][Full Text] [Related]
37. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy. Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974 [TBL] [Abstract][Full Text] [Related]
38. Primary transpupillary thermotherapy for 18 small posterior pole uveal melanomas. Spire M; Devouassoux MS; Kodjikian L; Janin-Magnificat H; Fleury J; Grange JD Am J Ophthalmol; 2006 May; 141(5):840-849. PubMed ID: 16678505 [TBL] [Abstract][Full Text] [Related]
39. Cytogenetic testing of iris melanoma using fine needle aspiration biopsy in 17 patients. Shields CL; Ramasubramanian A; Ganguly A; Mohan D; Shields JA Retina; 2011 Mar; 31(3):574-80. PubMed ID: 21336070 [TBL] [Abstract][Full Text] [Related]
40. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma. Meir T; Zeschnigk M; Masshöfer L; Pe'er J; Chowers I Invest Ophthalmol Vis Sci; 2007 May; 48(5):1918-22. PubMed ID: 17460242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]